APA (7th ed.) Citation

Zheng, H., Zhu, J., Joshi, M., Stein, M., Sankin, A., Kilari, D., . . . Degraff, D. J. (2023, February). Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: Results from phase II study, BTCRC-GU15-023. Journal for ImmunoTherapy of Cancer.

Chicago Style (17th ed.) Citation

Zheng, Hong, et al. "Concurrent Durvalumab and Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients with Localized Urothelial Cancer of Bladder: Results from Phase II Study, BTCRC-GU15-023." Journal for ImmunoTherapy of Cancer Feb. 2023.

MLA (9th ed.) Citation

Zheng, Hong, et al. "Concurrent Durvalumab and Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients with Localized Urothelial Cancer of Bladder: Results from Phase II Study, BTCRC-GU15-023." Journal for ImmunoTherapy of Cancer, Feb. 2023.